AI brings hope for patients with lysosomal storage disease

Artificial intelligence is becoming increasingly important in drug discovery. Advances in the use of Big Data, learning algorithms and powerful computers have now enabled researchers at the University of Zurich (UZH) to better understand a serious metabolic disease.

Leave A Comment

Your email address will not be published. Required fields are marked *